BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32359646)

  • 1. Natural ligands of RXR receptors.
    García P; Lorenzo P; de Lera AR
    Methods Enzymol; 2020; 637():209-234. PubMed ID: 32359646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in drug design with RXR modulators.
    Vaz B; de Lera ÁR
    Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
    Brtko J; Dvorak Z
    Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
    le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
    J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multi-faceted role of retinoid X receptor in bone remodeling.
    Menéndez-Gutiérrez MP; Ricote M
    Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
    DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
    Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.
    Sharma S; Shen T; Chitranshi N; Gupta V; Basavarajappa D; Sarkar S; Mirzaei M; You Y; Krezel W; Graham SL; Gupta V
    Mol Neurobiol; 2022 Apr; 59(4):2027-2050. PubMed ID: 35015251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
    Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
    J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid X Receptor Selective Agonists and their Synthetic Methods.
    Wagner CE; Jurutka PW; Marshall PA; Heck MC
    Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice.
    Rühl R; Krzyżosiak A; Niewiadomska-Cimicka A; Rochel N; Szeles L; Vaz B; Wietrzych-Schindler M; Álvarez S; Szklenar M; Nagy L; de Lera AR; Krężel W
    PLoS Genet; 2015 Jun; 11(6):e1005213. PubMed ID: 26030625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative retinoid X receptor (RXR) ligands.
    Krężel W; Rühl R; de Lera AR
    Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
    Kersten S; Dawson MI; Lewis BA; Noy N
    Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.